Cite
HARVARD Citation
Yu, Y. et al. (2022). Pharmacodynamic Modeling of CDK4/6 Inhibition‐Related Biomarkers and the Characterization of the Relationship Between Biomarker Response and Progression‐Free Survival in Patients With Advanced Breast Cancer. Journal of clinical pharmacology. pp. 376-384. [Online].